Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
57.1M
-
Number of holders
-
136
-
Total 13F shares, excl. options
-
44.3M
-
Shares change
-
+2.32M
-
Total reported value, excl. options
-
$1.89B
-
Value change
-
+$101M
-
Number of buys
-
88
-
Number of sells
-
-42
-
Price
-
$42.64
Significant Holders of Harmony Biosciences Holdings, Inc. - Common Stock (HRMY) as of Q4 2021
149 filings reported holding HRMY - Harmony Biosciences Holdings, Inc. - Common Stock as of Q4 2021.
Harmony Biosciences Holdings, Inc. - Common Stock (HRMY) has 136 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 44.3M shares
of 57.1M outstanding shares and own 77.62% of the company stock.
Largest 10 shareholders include Valor Management LLC (11.2M shares), Vivo Capital, LLC (4.88M shares), FMR LLC (4.21M shares), BlackRock Inc. (3.74M shares), venBio Partners LLC (2.74M shares), VANGUARD GROUP INC (2.66M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1.75M shares), JANUS HENDERSON GROUP PLC (1.54M shares), Blackstone Inc (1.05M shares), and Newlight Partners LP (901K shares).
This table shows the top 136 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.